Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial

Clinical trial NCT07551596 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07551596
Sponsor: National Cancer Institute (NCI)
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Adenocarcinoma Stage II Colorectal Cancer AJCC v8 Stage III Colorectal Cancer AJCC v8

Start date: 2026-08-14
Primary completion: 2026-09-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.